J.M. Farinhas

Radiological Society of North America (RSNA) 3D printing Special Interest Group (SIG): guidelines for medical 3D printing and appropriateness for clinical scenarios

Yoshimi Anzai, Philipp Brantner, Benjamin Johnson, 2018, 3D Printing in Medicine.

Federated learning enables big data for rare cancer boundary detection

Bjoern H Menze, Amber L. Simpson, James F. Gimpel, 2022, Nature Communications.

Occult Nodal Disease and Occult Extranodal Extension in Patients With Oropharyngeal Squamous Cell Carcinoma Undergoing Primary Transoral Robotic Surgery With Neck Dissection.

Joaquim M Farinhas, Wei Xu, D. Goldstein, 2019, JAMA otolaryngology-- head & neck surgery.

Comparison of the Prevalence of Ruptured and Unruptured Cerebral Aneurysms in a Poor Urban Minority Population.

Joaquim M Farinhas, D. Altschul, J. Bello, 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

CHAPTER 15 – Advanced MRI and PET Imaging of Meningiomas

Joaquim M Farinhas, J. Bello, J. Farinhas, 2010 .

Dynamic perfusion MRI characteristics of dural metastases and meningiomas: a pilot study characterizing the first-pass wash-in phase beyond relative cerebral blood volume.

Y. Lui, J. Farinhas, K. Weidenheim, 2011, AJR. American journal of roentgenology.

Covered stents safely utilized to prevent catastrophic hemorrhage in patients with advanced head and neck malignancy

J. Bello, J. Farinhas, J. Burns, 2011, Journal of NeuroInterventional Surgery.

Assessment of an Introductory Cervicocerebral Catheter Angiography Learning Program: A Pilot Study

Joaquim M Farinhas, Y. Lui, K. Freeman, 2012, American Journal of Neuroradiology.

NTRK3 gene fusion in an adult ganglioglioma: illustrative case

M. Vogelbaum, A. Perry, J. Farinhas, 2022, Journal of neurosurgery. Case lessons.

Phase II multi-institutional clinical trial result of concurrent cetuximab and nivolumab in recurrent and/or metastatic head and neck squamous cell carcinoma.

Joaquim M Farinhas, P. Stephens, D. Shin, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study

Joaquim M Farinhas, C. Chung, M. Schell, 2021, Cancers.